These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8542391)

  • 1. Long-term expression of genes in vivo using non-replicating HSV vectors.
    Bloom DC; Lokensgard JR; Maidment NT; Feldman LT; Stevens JG
    Gene Ther; 1994; 1 Suppl 1():S36-8. PubMed ID: 8542391
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term persistence of defective HSV-1 vectors in the rat brain is demonstrated by reactivation of vector gene expression.
    Starr PA; Lim F; Grant FD; Trask L; Lang P; Yu L; Geller AI
    Gene Ther; 1996 Jul; 3(7):615-23. PubMed ID: 8818649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector.
    Watanabe D; Brockman MA; Ndung'u T; Mathews L; Lucas WT; Murphy CG; Felber BK; Pavlakis GN; Deluca NA; Knipe DM
    Virology; 2007 Jan; 357(2):186-98. PubMed ID: 16996101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid insertion vectors that facilitate construction of herpes simplex virus gene delivery vectors.
    Weir JP; Dacquel EJ
    Gene; 1995 Feb; 154(1):123-8. PubMed ID: 7867939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus.
    Brubaker JO; Thompson CM; Morrison LA; Knipe DM; Siber GR; Finberg RW
    J Immunol; 1996 Aug; 157(4):1598-604. PubMed ID: 8759744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer with herpes simplex vectors.
    Lachmann RH; Efstathiou S
    Curr Opin Mol Ther; 1999 Oct; 1(5):622-32. PubMed ID: 11249669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minireview: the herpes simplex virus amplicon--a versatile defective virus vector.
    Frenkel N; Singer O; Kwong AD
    Gene Ther; 1994; 1 Suppl 1():S40-6. PubMed ID: 8542394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral vector systems for gene therapy.
    Jolly D
    Cancer Gene Ther; 1994 Mar; 1(1):51-64. PubMed ID: 7621239
    [No Abstract]   [Full Text] [Related]  

  • 10. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.
    Shuh M; Hill SA; Derse D
    Virology; 1999 Sep; 262(2):442-51. PubMed ID: 10502522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective herpes simplex virus vectors for the study of promoter and gene function in the CNS.
    New KC; Martuza RL; Rabkin SD
    Gene Ther; 1994; 1 Suppl 1():S79. PubMed ID: 8542425
    [No Abstract]   [Full Text] [Related]  

  • 12. Replication-defective herpes simplex virus vectors for gene transfer in vivo.
    Marconi P; Krisky D; Oligino T; Poliani PL; Ramakrishnan R; Goins WF; Fink DJ; Glorioso JC
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11319-20. PubMed ID: 8876133
    [No Abstract]   [Full Text] [Related]  

  • 13. Replication-defective recombinant herpes simplex virus vectors.
    Johnson PA; Friedmann T
    Methods Cell Biol; 1994; 43 Pt A():211-30. PubMed ID: 7823863
    [No Abstract]   [Full Text] [Related]  

  • 14. Herpes simplex virus vectors for gene therapy.
    Latchman DS
    Mol Biotechnol; 1994 Oct; 2(2):179-95. PubMed ID: 7866875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus latency-associated transcript sequence downstream of the promoter influences type-specific reactivation and viral neurotropism.
    Bertke AS; Patel A; Krause PR
    J Virol; 2007 Jun; 81(12):6605-13. PubMed ID: 17409161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
    Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
    Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of nuclear matrix attachment regions into the herpes simplex virus type 1 genome does not induce long-term expression of a foreign gene during latency.
    Makarova O; Gorneva G; Wu F; Farutin V; Villeponteau B; Poliani L; Fink D; Levine M
    Gene Ther; 1996 Sep; 3(9):829-33. PubMed ID: 8875233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpesviruses: expression of genes in postmitotic brain cells.
    Geller AI
    Curr Opin Genet Dev; 1993 Feb; 3(1):81-5. PubMed ID: 8384036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible gene expression of the human immunodeficiency virus LTR in a replication-incompetent herpes simplex virus vector.
    Warden MP; Weir JP
    Virology; 1996 Dec; 226(1):127-31. PubMed ID: 8941330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.